JKJulia Kozłowska

Julia Kozłowska

*This is an algorithmically generated author record based on publicly available information.

Julia Kozłowska has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ACCIDENTAL DISPLACEMENT OF DENTAL IMPLANTS INTO THE NASAL CAVITY: A LITERATURE REVIEW

    by Julia Kozłowska, Przemysław Siemiątkowski, Sylwia Skraińska, Agnieszka Kiedik, Kacper Zima, Zuzanna Pietruk, Jakub Chamier-Gliszczyński, Dominik Ryszard Płaza

    Background: Migration of dental implants into the nasal cavity is a rare but potentially serious complication, which may cause chronic discomfort, pain, recurrent sinus infections, and nasal discharge. Despite the high predictability of implant therapy, displacement into adjacent anatomical structures remains a diagnostic and therapeutic challenge. Aim: The aim of this review is to present the clinical characteristics of patients with dental implant migration into the nasal cavity, identify potential risk factors, and discuss preventive strategies and treatment options. Material and Methods: A literature search was conducted in PubMed using the terms: “Dental implants displace and nasal cavity,” “Dental implants,” “migration,” and “nasal cavity.” Titles and abstracts were screened, and full texts were retrieved for relevant articles. Eight articles reporting implant migration into the nasal cavity were included and analyzed for implant localization, symptoms, time to diagnosis, and method of removal. Results: The keyword “dental implant displaced” yielded 1,181 results, while “nasal cavity” returned 25,526 results. The combined keywords “dental implant” and “nasal cavity” identified 145 publications; after adding the term “migration,” the number of articles was reduced to 12. Following analysis, eight articles addressing implant migration into the nasal cavity were selected. Conclusions: Although extremely rare, migration of dental implants into the nasal cavity can cause serious clinical consequences. Endoscopic removal is the treatment of choice, allowing safe extraction and concurrent management of mucosal changes. Accurate radiological assessment using CBCT or CT, careful surgical planning, appropriate implant selection, and postoperative monitoring are crucial for prevention and management of this complication.

  • Open Access

    MANIFESTATIONS OF THE SKIN IN DERMATOMYOSITIS AND THEIR DIAGNOSTIC SIGNIFICANCE: A LITERATURE REVIEW

    by Sylwia Skraińska, Agnieszka Kiedik, Julia Kozłowska, Kacper Zima, Zuzanna Pietruk, Jakub Chamier-Gliszczyński, Dominik Płaza, Przemysław Siemiątkowski

    Background. Dermatomyositis (DM) is an idiopathic inflammatory myopathy in which characteristic cutaneous manifestations often precede or occur independently of muscle involvement. Skin findings are essential for diagnosis, phenotype classification and prognostic assessment, reflecting underlying immunopathologic processes. Aim of the study. To review and summarize current evidence on the spectrum of cutaneous manifestations in dermatomyositis, their associations with myositis-specific autoantibodies, and implications for prognosis, monitoring and management. Materials and methods. A narrative review of peer-reviewed literature was performed. Searches were conducted in PubMed and in the Medical University of Gdańsk (GUMed) online library catalog. Search terms included “dermatomyositis”, “cutaneous manifestations,” “autoantibodies” and related phenotype and outcome terms. Priority was given to recent cohort studies, key reviews and illustrative case series; articles in English and Polish were considered. Selected sources were synthesized qualitatively to describe clinical morphology, serologic correlations, validated skin assessment tools and therapeutic approaches. Conclusions. Classic cutaneous signs (heliotrope rash, Gottron papules/sign, shawl and V-neck distributions, poikiloderma) remain central to DM recognition. Distinct skin phenotypes correlate with specific autoantibodies (e.g., anti-MDA5 with ulcerations and high ILD risk; anti-TIF1-γ with extensive eruptions and malignancy association; anti-NXP2 with calcinosis). Standardized scoring (CDASI) aids objective assessment. Integrating detailed dermatologic evaluation with antibody profiling improves early diagnosis, risk stratification and individualized management. Prospective, phenotype-driven studies and refinement of classification criteria-particularly to better capture amyopathic variants-are needed.

  • Open Access

    TOTAL JOINT ARTHROPLASTY IN YOUNG PATIENTS: INDICATIONS, RISKS, AND LONG-TERM OUTCOMES

    by Kacper Zima, Agnieszka Kiedik, Zuzanna Pietruk, Jakub Chamier-Gliszczyński, Julia Kozłowska, Sylwia Skraińska, Przemysław Siemiątkowski, Dominik Ryszard Płaza

    Total joint arthroplasty (TJA) of the hip and knee is one of the most successful reconstructive procedures in modern orthopedics, providing significant pain relief and functional improvement. Over the past decades, a steady increase in the number of arthroplasty procedures performed in younger patients, commonly defined as individuals under 60 years of age, has been observed worldwide. This demographic shift poses unique clinical challenges, as younger patients present higher functional demands, longer life expectancy, and a substantially increased risk of revision surgery compared with elderly populations. The aim of this narrative review is to summarize current evidence regarding indications for total hip and knee arthroplasty in young patients, analyze perioperative and long-term risks, and discuss implant survivorship and functional outcomes. Furthermore, emerging technologies and treatment strategies designed to prolong implant longevity and delay revision surgery are reviewed. A comprehensive understanding of these factors is essential for appropriate patient selection, surgical planning, and long-term management of young individuals undergoing joint replacement.

  • Open Access

    ACUTE APPENDICITIS MANAGEMENT: HISTORICAL INSIGHTS, MODERN APPROACHES, AND FUTURE PERSPECTIVES

    by Przemysław Siemiątkowski, Agnieszka Kiedik, Kacper Zima, Zuzanna Pietruk, Jakub Chamier-Gliszczyński, Dominik Ryszard Płaza, Julia Kozłowska, Sylwia Skraińska

    Objectives: This narrative review aims to summarize the historical evolution, current manage-ment strategies, and emerging future directions in the treatment of acute appendicitis, emphasiz-ing the transition from historically fatal disease to modern, evidence-based care. Methods: A thorough review of the literature was conducted, summarizing historical medical texts, surgical publications, and recent clinical guidelines. Emphasis was placed on the evolu-tion of surgical techniques, antibiotic therapy, and non-operative management strategies, as well as recent innovations in minimally invasive and personalized care. Key Findings: Acute appendicitis represents a heterogeneous disease spectrum requiring indi-vidualized management. While open appendectomy historically served as the gold standard, laparoscopic appendectomy is now the first-line operative approach in most cases. Non-operative management with antibiotics is a viable option in carefully selected patients with un-complicated disease, although recurrence and treatment failure remain concerns. Management of complicated appendicitis continues to rely on timely source control, with selective use of con-servative and interventional strategies. Emerging trends include ambulatory surgery, personal-ized treatment algorithms, and experimental endoscopic approaches. Conclusions: Advances in surgical technique, antimicrobial therapy, and perioperative care have dramatically reduced appendicitis-related morbidity and mortality. Contemporary man-agement emphasizes patient selection, minimally invasive surgery, and value-based care. Future progress will depend on high-quality evidence supporting personalized and resource-efficient treatment pathways.

  • Open Access

    THE EFFECTIVENESS OF CONTROLLED SCALP COOLING ON CHEMOTHERAPY-INDUCED ALOPECIA - A LITERATURE REVIEW

    by Dominik Ryszard Płaza, Jakub Chamier-Gliszczyński, Aleksandra Boba, Przemysław Siemiątkowski, Kacper Zima, Zuzanna Pietruk, Agnieszka Kiedik, Julia Kozłowska, Sylwia Skraińska

    Chemotherapy-induced alopecia (CIA) constantly remains one of the most noticeable and stress-inducing side-effects of cancer therapy, despite new strategies and advances in therapeutic approaches. Even though usually reversable, hair loss carries serious psychological and social consequences that affect patients’ comfort, social confidence and self-image, as well as adherence to oncological treatment. This review considers pathophysiological processes connected to CIA, focusing especially on anagen effluvium caused by cytotoxic nature of chemotherapeutic agents affecting proliferating hair follicle cells and underlines individual adaptation and susceptibility. Attention is focused particularly on controlled, mechanized scalp cooling method as an additional preventative intervention. Existing evidence from current studies clearly demonstrates that scalp cooling reduces the incidence and severity of CIA significantly, especially when it comes to taxane-based therapeutic regimens, with a range of 50% to 70% of hair preservation. In other types of therapies, like anthracycline-based, scalp cooling effectiveness is more limited but still shows meaningful reduction in severity and later onset of alopecia. Scalp cooling effectiveness reaches further than clinical outcomes. It contributes to an improved life quality, maintenance of privacy and identity and more positive patient-reported data. This review also takes global disparities, safety and ethical issues under consideration. Overall, innovative supportive strategies in medicine, like scalp cooling, integrate biological efficacy and psychological and social benefits and further underscore the importance of patient-focused approach in contemporary medicine, including oncological care.

  • Open Access

    ARTIFICIAL INTELLIGENCE AS A DECISION TOOL FOR SKIN LESIONS TRIAGE IN PRIMARY CARE: A NARRATIVE REVIEW

    by Zuzanna Pietruk, Michał Kozicki, Przemysław Siemiątkowski, Agnieszka Kiedik, Sylwia Skraińska, Julia Kozłowska, Jakub Chamier-Gliszczyński, Dominik Ryszard Płaza, Kacper Zima

    Background: Skin lesions are one of the common reasons for consultations in primary care (PC). Among them, skin cancers are a key clinical challenge, where early detection is crucial for the patient’s prognosis. Primary care physicians (PCPs) are responsible for the initial classification of skin conditions, determining which cases require referral to a specialist. In recent years, solutions using artificial intelligence (AI) have been gaining growing interest in medicine, offering new possibilities for diagnostic support, including in the field of dermatology. Objectives: The aim of this narrative review is to analyze the literature on whether and how artificial intelligence (AI) can support primary care physicians in the initial classification of skin lesions. Methods: A comprehensive review of the literature regarding the application of artificial intelligence in skin cancer diagnosis was conducted. The analysis covered results from clinical trials and reviews identifying implementation barriers. Key findings: Results from recent multicenter clinical trials demonstrate that Artificial Intelligence algorithms achieve high diagnostic sensitivity for melanoma, as well as robust accuracy for non-melanoma skin cancers. Comparative studies indicate that while AI performance is comparable to that of board-certified dermatologists, it statistically outperforms less experienced physicians. Conclusion: The conclusions from the study indicate that artificial intelligence can support primary care physicians by increasing their diagnostic effectiveness in the triage of skin lesions. As a support tool, it has the potential to reduce the risk of missing cancers while reducing the number of unreasonable referrals to specialists. However, a key condition for introducing these technologies into everyday clinical practice is to resolve identified ethical and technological barriers.